Federal Supreme Court upholds mailing of abortion medication

The US Supreme Court has made a temporary decision to preserve nationwide mail access to mifepristone, a widely used abortion pill, by extending its stay of a lower court order that would have halted mail delivery of the medication.

n

This move comes after a panel of the US 5th Circuit Court of Appeals had previously ruled to stop mail access to mifepristone, which is utilized in the majority of abortions in the United States, but the Supreme Court's decision has put that ruling on hold until further review.

n

Two conservative justices, Samuel Alito and Clarence Thomas, have expressed dissent from the decision to extend the stay of the 5th Circuit decision, indicating a divide within the court on this matter.

n

The 5th Circuit ruling was a response to a lawsuit filed by the state of Louisiana, known for having some of the strictest anti-abortion laws in the country, against the Food and Drug Administration (FDA), which has approved mifepristone since 2000.

n

Danco Laboratories and GenBioPro, the manufacturers of mifepristone, had requested the Supreme Court to pause the appeals court order, allowing them time to prepare an emergency case to be brought before the top court.

n

If the 5th Circuit ruling were to take effect, it would require women seeking abortions across the United States to obtain mifepristone in person from health clinics, banning delivery by mail or through a pharmacy after using telemedicine.

n

This would be a significant change, as the conservative-dominated appeals court overturned a district court ruling that had allowed mifepristone to continue being delivered by mail while the FDA conducts a safety study of the drug.

n

Mifepristone is not only used for abortions but also for managing early miscarriages, and it has been approved by the FDA for over two decades, with its safety profile established through extensive use.

n

However, anti-abortion activists have raised concerns about the drug's safety, citing a study conducted by a conservative think tank, although this study did not undergo formal peer review.

n

Mifepristone, in combination with misoprostol, is approved for terminating pregnancies up to 70 days' gestation in the United States, working by preventing pregnancy progression and then emptying the uterus.

n

Since the Supreme Court overturned the landmark Roe v. Wade ruling in June 2022, more than 20 states have banned or restricted abortion, reflecting a shift in the legal landscape surrounding reproductive rights.

n

Public opinion polls indicate that a majority of Americans support continued access to safe abortion, despite efforts by conservative groups to limit or ban the procedure outright.

n

In a related development, the Supreme Court in 2024 rejected a bid to restrict mifepristone, ruling that anti-abortion groups and doctors challenging the medication lacked the legal standing to bring the case.